STOCK TITAN

Flow Sciences Appoints Michael Gesser as Chief Financial Officer

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Flow Sciences (ACOR) named Michael Gesser as chief financial officer effective April 8, 2026. Gesser, a Flow Sciences board member since 2021, will retain his board seat while overseeing finance, accounting, tax, treasury, FP&A and investor relations. The company highlights his 30+ years of life sciences financial leadership and ties to the RTP expansion opened in 2025.

Loading...
Loading translation...

Positive

  • CFO appointment effective April 8, 2026
  • Gesser has 30+ years of financial leadership experience
  • Served on Flow Sciences board since 2021
  • Prior CFO roles include Acorda Therapeutics (ACOR)
  • RTP office opened in 2025, strengthening regional presence

Negative

  • None.

Key Figures

Board tenure start: 2021 RTP office opening: 2025 Finance experience: more than 30 years +2 more
5 metrics
Board tenure start 2021 Year Michael Gesser joined Flow Sciences board of directors
RTP office opening 2025 Year Flow Sciences opened Research Triangle Park office
Finance experience more than 30 years Gesser’s financial leadership experience across life sciences and pharma
Company expertise more than 30 years Flow Sciences’ experience delivering containment solutions
ISO certification ISO 9001:2015 Quality management certification referenced in company description

Market Reality Check

Vol: Volume 0 is below the 20-...
normal vol
Volume Volume 0 is below the 20-day average of 30,308, indicating limited trading activity before this announcement. normal
Technical Price is trading below the 200-day moving average of 9.93, reflecting a weak longer-term trend pre-announcement.

Market Pulse Summary

This announcement centers on appointing a seasoned CFO with more than 30 years of life sciences fina...
Analysis

This announcement centers on appointing a seasoned CFO with more than 30 years of life sciences finance experience and prior board involvement since 2021. It underscores Flow Sciences’ growth focus, including the RTP office opened in 2025 and continued investment in containment solutions. Investors may track how this leadership change influences capital structure management, budgeting discipline, and support for expansion while the company operates under its ISO 9001:2015 quality framework.

Key Terms

iso 9001:2015
1 terms
iso 9001:2015 regulatory
"Backed by ISO 9001:2015 certification and proven performance data..."
ISO 9001:2015 is an international standard for a company's quality management system, describing a structured set of practices that help organizations consistently meet customer expectations and improve processes. For investors, an ISO 9001:2015 certification is like a verified recipe or checklist showing the company follows disciplined procedures to reduce mistakes, control costs, and protect reputation, which can lower operational risk and support steady performance.

AI-generated analysis. Not financial advice.

Life Sciences Finance Veteran and Flow Sciences Board Member Steps Into CFO Role to Support Company's Next Phase of Growth

RALEIGH, N.C, April 8, 2026 /PRNewswire/ -- Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Michael Gesser as its chief financial officer. Gesser, who has served as a member of the Flow Sciences board of directors since 2021, will continue serving on the board while assuming executive responsibility for all finance, accounting, tax, treasury, FP&A and investor relations functions.

Gesser brings more than 30 years of financial leadership experience across both publicly-traded and privately-held companies in the life sciences, pharmaceutical, and medical device sectors. His career includes CFO tenures at Acorda Therapeutics, Inc. (Nasdaq: ACOR), Osmotica Pharmaceutical, Tergus Pharma, BioMedomics, and SunTech Medical. He holds a B.S. from the Cameron School of Business at the University of North Carolina Wilmington and an MBA from the Belk College of Business at UNC Charlotte.

As a Flow Sciences board member, Gesser played an integral role in the company's strategic expansion into the Research Triangle Park (RTP) area of North Carolina, one of the nation's leading hubs for biopharmaceutical research, innovation, and manufacturing. The RTP office, which opened in 2025, features a state-of-the-art product showroom, training facilities, and a consultative design center, strengthening Flow Sciences' presence in a region with deep concentrations of pharmaceutical and biotechnology clients.

"Michael's appointment as CFO is a natural evolution of his already-significant contributions to Flow Sciences," said Jonathan Mann, Chief Executive Officer. "His deep financial expertise, his experience navigating both public and private company environments, and his long-standing familiarity with our business and strategy make him ideally suited to lead our financial function as we continue to grow. We're thrilled to have him step into this role."

In his new capacity, Gesser will partner closely with Mann and the broader executive team to oversee financial strategy, capital structure management, budgeting, forecasting and compliance. He will also support the company's ongoing growth initiatives, including expansion of its containment solutions portfolio and continued investment in the RTP area presence.

"I have had a front-row seat to Flow Sciences' evolution—the strength of its technology, the quality of its team, and the depth of its customer relationships," said Gesser. "I am honored to take on a more active role in driving the financial strategy that will support our next chapter. There is a tremendous opportunity ahead of us, and I look forward to helping the company capitalize on it."

About Flow Sciences

Flow Sciences delivers advanced containment solutions that help laboratories, manufacturers, and research organizations safely handle hazardous powders, fluids, and gases. With more than 30 years of expertise, the company engineers award-winning enclosures—such as the Vented Balance Safety Enclosure (VBSE™)—that meet rigorous safety regulations while optimizing workflow efficiency and minimizing downtime. Its modular, customizable systems are trusted worldwide across multiple industries. Flow Sciences provides expert engineering support for tailored containment solutions, guiding clients from design through installation, and offers comprehensive post-sales service to ensure ongoing performance and compliance. Backed by ISO 9001:2015 certification and proven performance data, Flow Sciences empowers organizations to protect personnel and products, simplify compliance, and maximize long-term value. For more information, visit flowsciences.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/flow-sciences-appoints-michael-gesser-as-chief-financial-officer-302736093.html

SOURCE Flow Sciences Inc

FAQ

When does Michael Gesser start as CFO of Flow Sciences (ACOR)?

He begins his role as chief financial officer on April 8, 2026. According to the company, he will assume responsibility for finance, accounting, tax, treasury, FP&A and investor relations while continuing to serve on the board.

What is Michael Gesser's background before joining Flow Sciences as CFO (ACOR)?

Gesser brings more than 30 years of financial leadership experience in life sciences and medical devices. According to the company, his career includes CFO tenures at Acorda Therapeutics (ACOR), Osmotica Pharmaceutical, Tergus Pharma, BioMedomics and SunTech Medical.

Will Michael Gesser remain a board member after becoming CFO of Flow Sciences (ACOR)?

Yes. He will continue serving on the Flow Sciences board while acting as CFO. According to the company, this maintains continuity and leverages his prior board role in supporting strategic and regional growth initiatives.

How does the RTP office relate to Flow Sciences' appointment of Michael Gesser (ACOR)?

The RTP presence is cited as strategic for regional clients and growth. According to the company, Gesser helped expand the Research Triangle Park location, which opened in 2025 with showroom, training and design facilities.

What responsibilities will Michael Gesser have as CFO of Flow Sciences (ACOR)?

He will oversee finance, accounting, tax, treasury, FP&A and investor relations. According to the company, Gesser will also partner on financial strategy, capital structure, budgeting, forecasting and compliance to support growth initiatives.